Clinical Trials Directory

Trials / Completed

CompletedNCT05717855

Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Gaziosmanpasa Research and Education Hospital · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP). Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.

Detailed description

Up to now, optic chiasm measurement were all done in the third trimester. in the present study, OC will be measure directly in a 2D ultrasound in coronal plane within the second trimester. In fetuses with SP agenesis, the morphology and width of the OC visual pathway may be a suitable tool to assess its development. It can also assist in the difficult task of providing prenatal counseling when faced with a diagnosis of CP agenesis. therefore In the present study, it was planned to show the optic chiasm in the screening of septooptic dysplasia by ultrasound between 16-20 weeks of gestation, and to measure the optic chiasma width and length, and to determine the mean values in the second trimester.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDisplaying optic chiasm for screening septooptic dysplasiaDisplaying and measuring the width and length of the optic chiasm for screening septooptic dysplasia with ultrasound between 16-20 weeks of gestation

Timeline

Start date
2020-09-21
Primary completion
2021-03-21
Completion
2021-04-21
First posted
2023-02-08
Last updated
2023-02-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05717855. Inclusion in this directory is not an endorsement.